img

Global Live-type Poultry Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Live-type Poultry Vaccine Market Insights, Forecast to 2034

A live-type poultry vaccine contains a virus or bacteria that must infect the chicken and multiply in its body to produce immunity, preferably with minimal reaction. Multiplication of the virus in the chicken is necessary, as only relatively small amounts of virus are administered to the bird.
The global Live-type Poultry Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Live-type Poultry Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Live-type Poultry Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Live-type Poultry Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Live-type Poultry Vaccine include MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Live-type Poultry Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Live-type Poultry Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Live-type Poultry Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Live-type Poultry Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Live-type Poultry Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Live-type Poultry Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc.



By Company


MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Segment by Type
Newcastle Disease Vaccine
Infectious Bronchitis Vaccine
Fowl Pox Vaccine
Marek’s Disease Vaccine
Fowl Typhoid Vaccine
Live Coccidiosis Vaccine
Other

Segment by Application


Chicken
Other Poultry

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Live-type Poultry Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Live-type Poultry Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live-type Poultry Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Live-type Poultry Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Live-type Poultry Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Newcastle Disease Vaccine
1.2.3 Infectious Bronchitis Vaccine
1.2.4 Fowl Pox Vaccine
1.2.5 Marek’s Disease Vaccine
1.2.6 Fowl Typhoid Vaccine
1.2.7 Live Coccidiosis Vaccine
1.2.8 Other
1.3 Market by Application
1.3.1 Global Live-type Poultry Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Chicken
1.3.3 Other Poultry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Live-type Poultry Vaccine Sales Estimates and Forecasts 2018-2034
2.2 Global Live-type Poultry Vaccine Revenue by Region
2.2.1 Global Live-type Poultry Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Live-type Poultry Vaccine Revenue by Region (2018-2024)
2.2.3 Global Live-type Poultry Vaccine Revenue by Region (2024-2034)
2.2.4 Global Live-type Poultry Vaccine Revenue Market Share by Region (2018-2034)
2.3 Global Live-type Poultry Vaccine Sales Estimates and Forecasts 2018-2034
2.4 Global Live-type Poultry Vaccine Sales by Region
2.4.1 Global Live-type Poultry Vaccine Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Live-type Poultry Vaccine Sales by Region (2018-2024)
2.4.3 Global Live-type Poultry Vaccine Sales by Region (2024-2034)
2.4.4 Global Live-type Poultry Vaccine Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Live-type Poultry Vaccine Sales by Manufacturers
3.1.1 Global Live-type Poultry Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Live-type Poultry Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Live-type Poultry Vaccine in 2022
3.2 Global Live-type Poultry Vaccine Revenue by Manufacturers
3.2.1 Global Live-type Poultry Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Live-type Poultry Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Live-type Poultry Vaccine Revenue in 2022
3.3 Global Key Players of Live-type Poultry Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Live-type Poultry Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Live-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Live-type Poultry Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Live-type Poultry Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Live-type Poultry Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Live-type Poultry Vaccine Sales by Type
4.1.1 Global Live-type Poultry Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Live-type Poultry Vaccine Forecasted Sales by Type (2024-2034)
4.1.3 Global Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Live-type Poultry Vaccine Revenue by Type
4.2.1 Global Live-type Poultry Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Live-type Poultry Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Live-type Poultry Vaccine Price by Type
4.3.1 Global Live-type Poultry Vaccine Price by Type (2018-2024)
4.3.2 Global Live-type Poultry Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Live-type Poultry Vaccine Sales by Application
5.1.1 Global Live-type Poultry Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Live-type Poultry Vaccine Forecasted Sales by Application (2024-2034)
5.1.3 Global Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Live-type Poultry Vaccine Revenue by Application
5.2.1 Global Live-type Poultry Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Live-type Poultry Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Live-type Poultry Vaccine Price by Application
5.3.1 Global Live-type Poultry Vaccine Price by Application (2018-2024)
5.3.2 Global Live-type Poultry Vaccine Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Live-type Poultry Vaccine Market Size by Type
6.1.1 US & Canada Live-type Poultry Vaccine Sales by Type (2018-2034)
6.1.2 US & Canada Live-type Poultry Vaccine Revenue by Type (2018-2034)
6.2 US & Canada Live-type Poultry Vaccine Market Size by Application
6.2.1 US & Canada Live-type Poultry Vaccine Sales by Application (2018-2034)
6.2.2 US & Canada Live-type Poultry Vaccine Revenue by Application (2018-2034)
6.3 US & Canada Live-type Poultry Vaccine Market Size by Country
6.3.1 US & Canada Live-type Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Live-type Poultry Vaccine Sales by Country (2018-2034)
6.3.3 US & Canada Live-type Poultry Vaccine Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Live-type Poultry Vaccine Market Size by Type
7.1.1 Europe Live-type Poultry Vaccine Sales by Type (2018-2034)
7.1.2 Europe Live-type Poultry Vaccine Revenue by Type (2018-2034)
7.2 Europe Live-type Poultry Vaccine Market Size by Application
7.2.1 Europe Live-type Poultry Vaccine Sales by Application (2018-2034)
7.2.2 Europe Live-type Poultry Vaccine Revenue by Application (2018-2034)
7.3 Europe Live-type Poultry Vaccine Market Size by Country
7.3.1 Europe Live-type Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Live-type Poultry Vaccine Sales by Country (2018-2034)
7.3.3 Europe Live-type Poultry Vaccine Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Live-type Poultry Vaccine Market Size
8.1.1 China Live-type Poultry Vaccine Sales (2018-2034)
8.1.2 China Live-type Poultry Vaccine Revenue (2018-2034)
8.2 China Live-type Poultry Vaccine Market Size by Application
8.2.1 China Live-type Poultry Vaccine Sales by Application (2018-2034)
8.2.2 China Live-type Poultry Vaccine Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Live-type Poultry Vaccine Market Size by Type
9.1.1 Asia Live-type Poultry Vaccine Sales by Type (2018-2034)
9.1.2 Asia Live-type Poultry Vaccine Revenue by Type (2018-2034)
9.2 Asia Live-type Poultry Vaccine Market Size by Application
9.2.1 Asia Live-type Poultry Vaccine Sales by Application (2018-2034)
9.2.2 Asia Live-type Poultry Vaccine Revenue by Application (2018-2034)
9.3 Asia Live-type Poultry Vaccine Sales by Region
9.3.1 Asia Live-type Poultry Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Live-type Poultry Vaccine Revenue by Region (2018-2034)
9.3.3 Asia Live-type Poultry Vaccine Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Live-type Poultry Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Live-type Poultry Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 MERCK
11.1.1 MERCK Company Information
11.1.2 MERCK Overview
11.1.3 MERCK Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 MERCK Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MERCK Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 ELANCO
11.3.1 ELANCO Company Information
11.3.2 ELANCO Overview
11.3.3 ELANCO Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 ELANCO Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ELANCO Recent Developments
11.4 QYH BIOTECH
11.4.1 QYH BIOTECH Company Information
11.4.2 QYH BIOTECH Overview
11.4.3 QYH BIOTECH Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 QYH BIOTECH Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 QYH BIOTECH Recent Developments
11.5 CEVA
11.5.1 CEVA Company Information
11.5.2 CEVA Overview
11.5.3 CEVA Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 CEVA Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CEVA Recent Developments
11.6 ZOETIS
11.6.1 ZOETIS Company Information
11.6.2 ZOETIS Overview
11.6.3 ZOETIS Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 ZOETIS Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ZOETIS Recent Developments
11.7 Vaxxinova
11.7.1 Vaxxinova Company Information
11.7.2 Vaxxinova Overview
11.7.3 Vaxxinova Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Vaxxinova Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Vaxxinova Recent Developments
11.8 PULIKE
11.8.1 PULIKE Company Information
11.8.2 PULIKE Overview
11.8.3 PULIKE Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 PULIKE Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 PULIKE Recent Developments
11.9 PHIBRO ANIMAL HEALTH CORPORATION
11.9.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
11.9.2 PHIBRO ANIMAL HEALTH CORPORATION Overview
11.9.3 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
11.10 JINYU BIOTECHNOLOGY
11.10.1 JINYU BIOTECHNOLOGY Company Information
11.10.2 JINYU BIOTECHNOLOGY Overview
11.10.3 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 JINYU BIOTECHNOLOGY Recent Developments
11.11 HARBIN PHARMACEUTICAL GROUP
11.11.1 HARBIN PHARMACEUTICAL GROUP Company Information
11.11.2 HARBIN PHARMACEUTICAL GROUP Overview
11.11.3 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 HARBIN PHARMACEUTICAL GROUP Recent Developments
11.12 MEVAC
11.12.1 MEVAC Company Information
11.12.2 MEVAC Overview
11.12.3 MEVAC Live-type Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 MEVAC Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 MEVAC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Live-type Poultry Vaccine Industry Chain Analysis
12.2 Live-type Poultry Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Live-type Poultry Vaccine Production Mode & Process
12.4 Live-type Poultry Vaccine Sales and Marketing
12.4.1 Live-type Poultry Vaccine Sales Channels
12.4.2 Live-type Poultry Vaccine Distributors
12.5 Live-type Poultry Vaccine Customers
13 Market Dynamics
13.1 Live-type Poultry Vaccine Industry Trends
13.2 Live-type Poultry Vaccine Market Drivers
13.3 Live-type Poultry Vaccine Market Challenges
13.4 Live-type Poultry Vaccine Market Restraints
14 Key Findings in The Global Live-type Poultry Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Live-type Poultry Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Newcastle Disease Vaccine
Table 3. Major Manufacturers of Infectious Bronchitis Vaccine
Table 4. Major Manufacturers of Fowl Pox Vaccine
Table 5. Major Manufacturers of Marek’s Disease Vaccine
Table 6. Major Manufacturers of Fowl Typhoid Vaccine
Table 7. Major Manufacturers of Live Coccidiosis Vaccine
Table 8. Major Manufacturers of Other
Table 9. Global Live-type Poultry Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Live-type Poultry Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Live-type Poultry Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 12. Global Live-type Poultry Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Live-type Poultry Vaccine Revenue Market Share by Region (2018-2024)
Table 14. Global Live-type Poultry Vaccine Revenue Market Share by Region (2024-2034)
Table 15. Global Live-type Poultry Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 16. Global Live-type Poultry Vaccine Sales by Region (2018-2024) & (K Units)
Table 17. Global Live-type Poultry Vaccine Sales by Region (2024-2034) & (K Units)
Table 18. Global Live-type Poultry Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Live-type Poultry Vaccine Sales Market Share by Region (2024-2034)
Table 20. Global Live-type Poultry Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 21. Global Live-type Poultry Vaccine Sales Share by Manufacturers (2018-2024)
Table 22. Global Live-type Poultry Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 23. Global Live-type Poultry Vaccine Revenue Share by Manufacturers (2018-2024)
Table 24. Global Key Players of Live-type Poultry Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 25. Live-type Poultry Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 26. Global Live-type Poultry Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Live-type Poultry Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live-type Poultry Vaccine as of 2022)
Table 28. Global Key Manufacturers of Live-type Poultry Vaccine, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Live-type Poultry Vaccine, Product Offered and Application
Table 30. Global Key Manufacturers of Live-type Poultry Vaccine, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Live-type Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 33. Global Live-type Poultry Vaccine Sales by Type (2024-2034) & (K Units)
Table 34. Global Live-type Poultry Vaccine Sales Share by Type (2018-2024)
Table 35. Global Live-type Poultry Vaccine Sales Share by Type (2024-2034)
Table 36. Global Live-type Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 37. Global Live-type Poultry Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Live-type Poultry Vaccine Revenue Share by Type (2018-2024)
Table 39. Global Live-type Poultry Vaccine Revenue Share by Type (2024-2034)
Table 40. Live-type Poultry Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 41. Global Live-type Poultry Vaccine Price Forecast by Type (2024-2034) & (US$/Unit)
Table 42. Global Live-type Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 43. Global Live-type Poultry Vaccine Sales by Application (2024-2034) & (K Units)
Table 44. Global Live-type Poultry Vaccine Sales Share by Application (2018-2024)
Table 45. Global Live-type Poultry Vaccine Sales Share by Application (2024-2034)
Table 46. Global Live-type Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 47. Global Live-type Poultry Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Live-type Poultry Vaccine Revenue Share by Application (2018-2024)
Table 49. Global Live-type Poultry Vaccine Revenue Share by Application (2024-2034)
Table 50. Live-type Poultry Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 51. Global Live-type Poultry Vaccine Price Forecast by Application (2024-2034) & (US$/Unit)
Table 52. US & Canada Live-type Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 53. US & Canada Live-type Poultry Vaccine Sales by Type (2024-2034) & (K Units)
Table 54. US & Canada Live-type Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 55. US & Canada Live-type Poultry Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 56. US & Canada Live-type Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 57. US & Canada Live-type Poultry Vaccine Sales by Application (2024-2034) & (K Units)
Table 58. US & Canada Live-type Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 59. US & Canada Live-type Poultry Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 60. US & Canada Live-type Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. US & Canada Live-type Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 62. US & Canada Live-type Poultry Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 63. US & Canada Live-type Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 64. US & Canada Live-type Poultry Vaccine Sales by Country (2024-2034) & (K Units)
Table 65. Europe Live-type Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 66. Europe Live-type Poultry Vaccine Sales by Type (2024-2034) & (K Units)
Table 67. Europe Live-type Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Live-type Poultry Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Live-type Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 70. Europe Live-type Poultry Vaccine Sales by Application (2024-2034) & (K Units)
Table 71. Europe Live-type Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Live-type Poultry Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Live-type Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Live-type Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Live-type Poultry Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Live-type Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 77. Europe Live-type Poultry Vaccine Sales by Country (2024-2034) & (K Units)
Table 78. China Live-type Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 79. China Live-type Poultry Vaccine Sales by Type (2024-2034) & (K Units)
Table 80. China Live-type Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 81. China Live-type Poultry Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 82. China Live-type Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 83. China Live-type Poultry Vaccine Sales by Application (2024-2034) & (K Units)
Table 84. China Live-type Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 85. China Live-type Poultry Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 86. Asia Live-type Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 87. Asia Live-type Poultry Vaccine Sales by Type (2024-2034) & (K Units)
Table 88. Asia Live-type Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 89. Asia Live-type Poultry Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 90. Asia Live-type Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 91. Asia Live-type Poultry Vaccine Sales by Application (2024-2034) & (K Units)
Table 92. Asia Live-type Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 93. Asia Live-type Poultry Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 94. Asia Live-type Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 95. Asia Live-type Poultry Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 96. Asia Live-type Poultry Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 97. Asia Live-type Poultry Vaccine Sales by Region (2018-2024) & (K Units)
Table 98. Asia Live-type Poultry Vaccine Sales by Region (2024-2034) & (K Units)
Table 99. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Type (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Application (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 108. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales by Country (2024-2034) & (K Units)
Table 112. MERCK Company Information
Table 113. MERCK Description and Major Businesses
Table 114. MERCK Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. MERCK Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. MERCK Recent Developments
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Description and Major Businesses
Table 119. Boehringer Ingelheim Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Boehringer Ingelheim Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Boehringer Ingelheim Recent Developments
Table 122. ELANCO Company Information
Table 123. ELANCO Description and Major Businesses
Table 124. ELANCO Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. ELANCO Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. ELANCO Recent Developments
Table 127. QYH BIOTECH Company Information
Table 128. QYH BIOTECH Description and Major Businesses
Table 129. QYH BIOTECH Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. QYH BIOTECH Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. QYH BIOTECH Recent Developments
Table 132. CEVA Company Information
Table 133. CEVA Description and Major Businesses
Table 134. CEVA Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. CEVA Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. CEVA Recent Developments
Table 137. ZOETIS Company Information
Table 138. ZOETIS Description and Major Businesses
Table 139. ZOETIS Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. ZOETIS Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. ZOETIS Recent Developments
Table 142. Vaxxinova Company Information
Table 143. Vaxxinova Description and Major Businesses
Table 144. Vaxxinova Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Vaxxinova Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Vaxxinova Recent Developments
Table 147. PULIKE Company Information
Table 148. PULIKE Description and Major Businesses
Table 149. PULIKE Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. PULIKE Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PULIKE Recent Developments
Table 152. PHIBRO ANIMAL HEALTH CORPORATION Company Information
Table 153. PHIBRO ANIMAL HEALTH CORPORATION Description and Major Businesses
Table 154. PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
Table 157. JINYU BIOTECHNOLOGY Company Information
Table 158. JINYU BIOTECHNOLOGY Description and Major Businesses
Table 159. JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. JINYU BIOTECHNOLOGY Recent Developments
Table 162. HARBIN PHARMACEUTICAL GROUP Company Information
Table 163. HARBIN PHARMACEUTICAL GROUP Description and Major Businesses
Table 164. HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. HARBIN PHARMACEUTICAL GROUP Recent Developments
Table 167. MEVAC Company Information
Table 168. MEVAC Description and Major Businesses
Table 169. MEVAC Live-type Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. MEVAC Live-type Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. MEVAC Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Live-type Poultry Vaccine Distributors List
Table 175. Live-type Poultry Vaccine Customers List
Table 176. Live-type Poultry Vaccine Market Trends
Table 177. Live-type Poultry Vaccine Market Drivers
Table 178. Live-type Poultry Vaccine Market Challenges
Table 179. Live-type Poultry Vaccine Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Live-type Poultry Vaccine Product Picture
Figure 2. Global Live-type Poultry Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Live-type Poultry Vaccine Market Share by Type in 2022 & 2034
Figure 4. Newcastle Disease Vaccine Product Picture
Figure 5. Infectious Bronchitis Vaccine Product Picture
Figure 6. Fowl Pox Vaccine Product Picture
Figure 7. Marek’s Disease Vaccine Product Picture
Figure 8. Fowl Typhoid Vaccine Product Picture
Figure 9. Live Coccidiosis Vaccine Product Picture
Figure 10. Other Product Picture
Figure 11. Global Live-type Poultry Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 12. Global Live-type Poultry Vaccine Market Share by Application in 2022 & 2034
Figure 13. Chicken
Figure 14. Other Poultry
Figure 15. Live-type Poultry Vaccine Report Years Considered
Figure 16. Global Live-type Poultry Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Live-type Poultry Vaccine Revenue 2018-2034 (US$ Million)
Figure 18. Global Live-type Poultry Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 19. Global Live-type Poultry Vaccine Revenue Market Share by Region (2018-2034)
Figure 20. Global Live-type Poultry Vaccine Sales 2018-2034 ((K Units)
Figure 21. Global Live-type Poultry Vaccine Sales Market Share by Region (2018-2034)
Figure 22. US & Canada Live-type Poultry Vaccine Sales YoY (2018-2034) & (K Units)
Figure 23. US & Canada Live-type Poultry Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Live-type Poultry Vaccine Sales YoY (2018-2034) & (K Units)
Figure 25. Europe Live-type Poultry Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Live-type Poultry Vaccine Sales YoY (2018-2034) & (K Units)
Figure 27. China Live-type Poultry Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Asia (excluding China) Live-type Poultry Vaccine Sales YoY (2018-2034) & (K Units)
Figure 29. Asia (excluding China) Live-type Poultry Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales YoY (2018-2034) & (K Units)
Figure 31. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Live-type Poultry Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Live-type Poultry Vaccine in the World: Market Share by Live-type Poultry Vaccine Revenue in 2022
Figure 34. Global Live-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
Figure 36. Global Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
Figure 37. Global Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
Figure 38. Global Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
Figure 40. US & Canada Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
Figure 41. US & Canada Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
Figure 42. US & Canada Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
Figure 43. US & Canada Live-type Poultry Vaccine Revenue Share by Country (2018-2034)
Figure 44. US & Canada Live-type Poultry Vaccine Sales Share by Country (2018-2034)
Figure 45. U.S. Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
Figure 48. Europe Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
Figure 49. Europe Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
Figure 50. Europe Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
Figure 51. Europe Live-type Poultry Vaccine Revenue Share by Country (2018-2034)
Figure 52. Europe Live-type Poultry Vaccine Sales Share by Country (2018-2034)
Figure 53. Germany Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. France Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. China Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
Figure 59. China Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
Figure 60. China Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
Figure 61. China Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
Figure 62. Asia Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
Figure 63. Asia Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
Figure 64. Asia Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
Figure 65. Asia Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
Figure 66. Asia Live-type Poultry Vaccine Revenue Share by Region (2018-2034)
Figure 67. Asia Live-type Poultry Vaccine Sales Share by Region (2018-2034)
Figure 68. Japan Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 69. South Korea Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 70. China Taiwan Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 71. Southeast Asia Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 72. India Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales Market Share by Type (2018-2034)
Figure 74. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue Market Share by Type (2018-2034)
Figure 75. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales Market Share by Application (2018-2034)
Figure 76. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue Market Share by Application (2018-2034)
Figure 77. Middle East, Africa and Latin America Live-type Poultry Vaccine Revenue Share by Country (2018-2034)
Figure 78. Middle East, Africa and Latin America Live-type Poultry Vaccine Sales Share by Country (2018-2034)
Figure 79. Brazil Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 80. Mexico Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 81. Turkey Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 82. Israel Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 83. GCC Countries Live-type Poultry Vaccine Revenue (2018-2034) & (US$ Million)
Figure 84. Live-type Poultry Vaccine Value Chain
Figure 85. Live-type Poultry Vaccine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed